| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
1,728 |
1,583 |
$156K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
1,497 |
1,369 |
$128K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
571 |
493 |
$68K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
759 |
732 |
$47K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
610 |
581 |
$29K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
368 |
347 |
$15K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
182 |
152 |
$6K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
534 |
511 |
$5K |
| 99000 |
|
1,407 |
1,326 |
$2K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
57 |
40 |
$1K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
19 |
12 |
$687.60 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
31 |
30 |
$480.20 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
17 |
13 |
$443.54 |
| 99072 |
|
2,455 |
2,334 |
$82.50 |
| 99051 |
|
121 |
108 |
$0.00 |